Rojas Restrepo, J. L., Caballero Oteyza, A., Hübscher, K., Haberstroh, H., Fliegauf, M., Keller, B., Kobbe, R., Warnatz, K., Ehl, S., Proietti, M., & Grimbacher, B. (ca. 2022). Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study [Cd]. Universität. https://doi.org/10.3389/fimmu.2021.786516

Rojas Restrepo, J. L., Caballero Oteyza, A., Hübscher, K., Haberstroh, H., Fliegauf, M., Keller, B., Kobbe, R., Warnatz, K., Ehl, S., Proietti, M. und Grimbacher, B. (2022) Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study, Freiburg, Universität [Online]. DOI: 10.3389/fimmu.2021.786516.

[1]J. L. Rojas Restrepo, Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study. Freiburg: Universität, 2022. doi: 10.3389/fimmu.2021.786516.

1. Rojas Restrepo JL, Caballero Oteyza A, Hübscher K, Haberstroh H, Fliegauf M, Keller B, Kobbe R, Warnatz K, Ehl S, Proietti M, Grimbacher B. Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study. Freiburg: Universität; 2022. 1 Online-Ressource.

Rojas Restrepo, J. L./Caballero Oteyza, A./Hübscher, K./Haberstroh, H./Fliegauf, M./Keller, B./Kobbe, R./Warnatz, K./Ehl, S./Proietti, M./Grimbacher, B. (2022), Establishing the molecular diagnoses in a cohort of 291 patients with predominantly antibody deficiency by targeted next-generation sequencing: Experience from a monocentric study, Freiburg.